BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30442938)

  • 41. Retraction: "Identification of Novel Biomarkers for Pancreatic Cancer Using Integrated Transcriptomics With Functional Pathways Analysis" by Zhang, X., Tong, P., Chen, J., Pei, Z., Zhang, X., Chen, W., Xu, J., and Wang, J.
    J Cell Physiol; 2018 Nov; ():. PubMed ID: 30443987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.
    Ebbing EA; van der Zalm AP; Steins A; Creemers A; Hermsen S; Rentenaar R; Klein M; Waasdorp C; Hooijer GKJ; Meijer SL; Krishnadath KK; Punt CJA; van Berge Henegouwen MI; Gisbertz SS; van Delden OM; Hulshof MCCM; Medema JP; van Laarhoven HWM; Bijlsma MF
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2237-2242. PubMed ID: 30670657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of ADAM12 as a Novel Basigin Sheddase.
    Albrechtsen R; Wewer Albrechtsen NJ; Gnosa S; Schwarz J; Dyrskjøt L; Kveiborg M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ADAM12 silencing promotes cellular apoptosis by activating autophagy in choriocarcinoma cells.
    Wang L; Tan Z; Zhang Y; Kady Keita N; Liu H; Zhang Y
    Int J Oncol; 2020 May; 56(5):1162-1174. PubMed ID: 32319603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
    Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Córdoba A; Azúa YR; Aguiar B; Beloqui R; Armendáriz P; Arriola M; Martín-Sánchez E; Guerrero-Setas D
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
    Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
    Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer.
    Strijker M; van der Sijde F; Suker M; Boermeester MA; Bonsing BA; Bruno MJ; Busch OR; Doukas M; van Eijck CH; Gerritsen A; Groot Koerkamp B; Haj Mohammad N; van Hilst J; de Hingh IH; van Hooft JE; Luyer MD; Quintus Molenaar I; Verheij J; Waasdorp C; Wilmink JW; Besselink MG; van Laarhoven HW; Bijlsma MF;
    HPB (Oxford); 2021 Dec; 23(12):1886-1896. PubMed ID: 34103247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depletion of slow-cycling PDGFRα
    Di Carlo SE; Raffenne J; Varet H; Ode A; Granados DC; Stein M; Legendre R; Tuckermann J; Bousquet C; Peduto L
    Nat Immunol; 2023 Nov; 24(11):1867-1878. PubMed ID: 37798557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
    Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
    Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADAM12 is an independent predictor of poor prognosis in liver cancer.
    Du S; Sun L; Wang Y; Zhu W; Gao J; Pei W; Zhang Y
    Sci Rep; 2022 Apr; 12(1):6634. PubMed ID: 35459884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
    Ten Hoorn S; Waasdorp C; van Oijen MGH; Damhofer H; Trinh A; Zhao L; Smits LJH; Bootsma S; van Pelt GW; Mesker WE; Mol L; Goey KKH; Koopman M; Medema JP; Tuynman JB; Zlobec I; Punt CJA; Vermeulen L; Bijlsma MF
    BMC Cancer; 2022 Apr; 22(1):394. PubMed ID: 35413826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
    Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
    Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects and prognostic values of miR-30c-5p target genes in gastric cancer via a comprehensive analysis using bioinformatics.
    Hu S; Liu H; Zhang J; Li S; Zhou H; Gao Y
    Sci Rep; 2021 Oct; 11(1):20584. PubMed ID: 34663825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic cancer in 2021: What you need to know to win.
    Tonini V; Zanni M
    World J Gastroenterol; 2021 Sep; 27(35):5851-5889. PubMed ID: 34629806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
    Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
    Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma.
    Huang Z; Lai H; Liao J; Cai J; Li B; Meng L; Wang W; Mo X; Qin H
    Front Oncol; 2021; 11():729230. PubMed ID: 34604068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-29a-3p enhances the radiosensitivity of oral squamous cell carcinoma cells by inhibiting ADAM12.
    Jiang C; Liu F; Xiao S; He L; Wu W; Zhao Q
    Eur J Histochem; 2021 Sep; 65(3):. PubMed ID: 34587717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis.
    Wang R; Godet I; Yang Y; Salman S; Lu H; Lyu Y; Zuo Q; Wang Y; Zhu Y; Chen C; He J; Gilkes DM; Semenza GL
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33952697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins.
    Liot S; Balas J; Aubert A; Prigent L; Mercier-Gouy P; Verrier B; Bertolino P; Hennino A; Valcourt U; Lambert E
    Front Immunol; 2021; 12():612271. PubMed ID: 33889150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma.
    Jaworek C; Verel-Yilmaz Y; Driesch S; Ostgathe S; Cook L; Wagner S; Bartsch DK; Slater EP; Bartsch JW
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33578644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.